<p>We talk with Dr. Laura VanBlargen, a staff scientist, about her work to develop and characterize new monoclonal antibody-based therapies for SARS-CoV-2.</p>

We talk with Dr. Laura VanBlargen, a staff scientist, about her work to develop and characterize new monoclonal antibody-based therapies for SARS-CoV-2.

LMtV Episode 15: harnessing the immune response to develop therapies

Meet the people behind today’s virology headlines. People just like you working to understand viruses and how they affect you.
Host: Larissa Thackray, Ph.D., Professor of Infectious Diseases

Science

Medicine

Health & Fitness

Education

Life Sciences

Meet the people behind today’s virology headlines. People just like you working to understand viruses and how they affect you. Host: Larissa Thackray, Ph.D., Professor of Infectious Diseases

Share LMtV Episode 15: harnessing the immune response to develop therapies

Sign up to save your podcasts

LMtV Episode 15: harnessing the immune response to develop therapies

LMtV Episode 15: harnessing the immune response to develop therapies